Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)
China
· Delayed Price · Currency is CNY 22.16
+0.60 (2.78%)
Apr 1, 2025, 2:45 PM CST
SHE:000403 Revenue
Pacific Shuanglin Bio-pharmacy Co., LTD had revenue of 754.09M CNY in the quarter ending September 30, 2024, with 13.27% growth. This brings the company's revenue in the last twelve months to 2.84B, up 24.39% year-over-year. In the year 2023, Pacific Shuanglin Bio-pharmacy Co., LTD had annual revenue of 2.33B, down -3.18%.
Revenue (ttm)
2.84B
Revenue Growth
+24.39%
P/S Ratio
5.70
Revenue / Employee
1.17M
Employees
2,426
Market Cap
16.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.33B | -76.47M | -3.18% |
| Jan 1, 2023 | 2.41B | 433.45M | 21.98% |
| Jan 1, 2022 | 1.97B | 921.80M | 87.80% |
| Jan 1, 2021 | 1.05B | 134.28M | 14.67% |
| Jan 1, 2020 | 915.66M | 55.81M | 6.49% |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 26.00B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |